7Baggers
 Kiniksa (KNSA) Chief Strategy Officer named as insider in Form 3  Stock Titan Mon, 06 Jul 2026 20:37:31 GMT
 Kiniksa Pharmaceuticals stock hits all-time high at 64.85 USD  Investing.com Mon, 06 Jul 2026 14:34:34 GMT
 Kiniksa Pharmaceuticals updates investors on business progress  AD HOC NEWS Fri, 03 Jul 2026 16:16:43 GMT
 Kiniksa Pharmaceuticals International PLC (KNSA) Shares Surge 5.  GuruFocus Tue, 30 Jun 2026 00:01:06 GMT
 KNSA Maintained by Wedbush -- Price Target Raised to $72.00  GuruFocus Mon, 29 Jun 2026 23:40:11 GMT
 Kiniksa Pharmaceuticals International (MEX:KNSAN) Cyclicall  GuruFocus Mon, 29 Jun 2026 03:29:50 GMT
 knsa forecast — price target — prediction for 2027  TradingView Fri, 26 Jun 2026 14:16:28 GMT
 Here's Why You Should Add Kiniksa Stock to Your Portfolio Now  Yahoo Finance Fri, 26 Jun 2026 07:00:00 GMT
 knsa forecast — price target — prediction for 2027  TradingView Thu, 25 Jun 2026 21:22:35 GMT
 US High Growth Tech Stocks to Watch  simplywall.st Wed, 24 Jun 2026 07:00:00 GMT
 Biotech Kiniksa Pushes Toward A Buy Zone With Blockbuster Drug Sales In View  Investor's Business Daily Tue, 23 Jun 2026 19:11:00 GMT
 Kiniksa Pharmaceuticals stock hits all-time high of 59.89 USD  Investing.com Tue, 23 Jun 2026 07:00:00 GMT
 kiniksa pharmaceuticals international plc  TradingKey Tue, 23 Jun 2026 07:00:00 GMT
 Is Kiniksa Pharmaceuticals International PLC (KNSA) Overvalued A  GuruFocus Tue, 23 Jun 2026 01:01:34 GMT
 3 US Pharmaceutical Stocks With Strong Margins And Earnings Growth  simplywall.st Fri, 19 Jun 2026 07:00:00 GMT
 kiniksa pharmaceuticals international plc  TradingKey Thu, 18 Jun 2026 09:36:25 GMT
 How (KNSA) Movements Inform Risk Allocation Models  Stock Traders Daily Tue, 16 Jun 2026 10:00:02 GMT
 kiniksa pharmaceuticals, ltd.  MLQ.ai Mon, 08 Jun 2026 21:30:33 GMT
 trading systems reacting to (knsa) volatility  Stock Traders Daily Fri, 05 Jun 2026 08:30:02 GMT
 219,591-share cashless exercise reported by kiniksa (nasdaq: knsa)  Stock Titan Thu, 04 Jun 2026 18:07:37 GMT
 kiniksa pharmaceuticals, ltd.  MLQ.ai Tue, 02 Jun 2026 11:11:29 GMT
 kiniksa (knsa) director receives rsus and options in equity grants  Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
 kiniksa (knsa) q1 2026 earnings transcript  The Globe and Mail Mon, 01 Jun 2026 07:00:00 GMT
 kiniksa shareholders reelect directors and approve auditor mandates  The Globe and Mail Sat, 30 May 2026 22:00:00 GMT
 biotech stocks facing fda decision in june 2026  RTTNews Sat, 30 May 2026 14:41:00 GMT
 kiniksa pharmaceuticals to present at upcoming investor conferences  The Manila Times Sat, 30 May 2026 07:00:00 GMT
 Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences  Yahoo Finance Fri, 29 May 2026 07:00:00 GMT
 baker bros sets 49.9% voting cap in kiniksa (nasdaq: knsa)  Stock Titan Tue, 26 May 2026 07:00:00 GMT
 how kiniksa pharmaceuticals ltd. (knsa) affects rotational strategy timing  Stock Traders Daily Mon, 25 May 2026 07:22:02 GMT
 Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally  Yahoo Finance Sat, 23 May 2026 07:00:00 GMT
 (knsa) and the role of price-sensitive allocations  Stock Traders Daily Thu, 14 May 2026 06:14:01 GMT
 kiniksa pharmaceuticals international : 2025 annual report  marketscreener.com Fri, 08 May 2026 17:33:07 GMT
 Kiniksa Q1 2026 slides: ARCALYST revenue surges 56%, guidance raised  Investing.com Fri, 08 May 2026 07:00:00 GMT
 kiniksa pharmaceuticals stock hits all-time high at 58.23 usd by investing.com  Investing.com Nigeria Thu, 07 May 2026 04:35:17 GMT
 kiniksa pharmaceuticals stock hits all-time high at 58.23 usd  Investing.com Wed, 06 May 2026 07:00:00 GMT
 fmr llc amends filing showing 6,787,700.23 kiniksa holdings (knsa)  Stock Titan Wed, 06 May 2026 07:00:00 GMT
 responsive playbooks and the knsa inflection  Stock Traders Daily Sun, 03 May 2026 07:00:00 GMT
 kiniksa pharmaceuticals arcalyst net sales guidance reaches $945 million  HarianBasis.co Sat, 02 May 2026 09:38:14 GMT

Kiniksa Pharmaceuticals, Ltd
(NASDAQ:KNSA) 

KNSA stock logo

Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need worldwide. Its product candidates include Rilonace...

Founded: 2015
Full Time Employees: 135
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends